Edgewater-Backed Deerfield Platform Invests in Deerfield Agency

Deerfield Agency (Edgewater-backed) Acquires Verge Scientific Communications

July 26, 2022

Marketing & Advertising

Deerfield Agency, a portfolio company of The Edgewater Funds, has acquired Verge Scientific Communications, a Virginia-based brand strategy and strategic communications agency serving life sciences and science-driven companies. The acquisition brings Verge's ~40-person team and scientific communications capabilities into Deerfield to deepen services for pre-commercial biotech, pharmaceutical and health-technology clients as an add-on to Deerfield's platform.

Deerfield Agency Acquires Embedded

June 6, 2024

Marketing & Advertising

Deerfield Agency (part of Deerfield Group) has acquired Embedded, a New Jersey-based healthcare marketing and advertising firm, and folded it together with Verge Scientific Communications under the Deerfield Group brand. The deal brings Embedded’s brand strategy, planning, and creative capabilities into Deerfield’s integrated life‑sciences marketing platform, with Embedded principals joining Deerfield Group’s leadership team.

Edgewater Growth Capital Partners Invests in Boulden Company, Inc.

August 8, 2025

Manufacturing

Edgewater Growth Capital Partners V, L.P. (The Edgewater Funds) has made an investment in Boulden Company, Inc., a Conshohocken, Pennsylvania-based supplier of wear components and services for high-value reciprocating and rotating equipment. The investment launches a new Edgewater platform focused on aftermarket wear components, materials solutions, and services; Edgewater plans to scale the platform through organic growth and strategic add-on acquisitions while partnering with founder Brian Boulden and the existing management team.

Edgewater Capital Partners Invests in CBCC Global Research

May 27, 2025

Healthcare Services

Edgewater Capital Partners, a Cleveland-based private equity firm, has partnered with the shareholders and management of CBCC Global Research, a Bakersfield-headquartered clinical contract research organization (CRO). Edgewater's investment will support CBCC's growth by funding people, technology, and infrastructure to expand its clinical trial services across oncology, CNS, ophthalmology and other therapeutic areas.

Edgewater Capital Partners Acquires GL CHEMTEC

August 11, 2022

Pharmaceuticals

Edgewater Capital Partners, a Cleveland-based lower middle-market private equity firm, has acquired GL CHEMTEC, a chemistry-based contract research organization (CRO) headquartered in Oakville, Ontario. Edgewater will support GLC's expansion of API development, scale-up and advanced materials capabilities to accelerate growth across North American pharma and life-sciences customers.

Edgewater (Flex Pack) Acquires Flexible Packaging Specialties, Inc. (FPS)

August 8, 2022

Packaging

Edgewater Growth Capital Partners IV has acquired Flexible Packaging Specialties, Inc. (FPS), a Loveland, Ohio-based flexible packaging manufacturer, as an add-on to its Flex Pack platform. The acquisition expands Flex Pack’s flexible packaging capabilities and continues the platform’s roll-up strategy under leader Scott Myers.